affiliation not provided to SSRN
Non-small cell lung cancer, Suvemcitug, Anti-angiogenesis, Envafolimab, immune checkpoint inhibitor
Trilaciclib, Chemotherapy-induced myelosuppression, Extensive-stage small-cell lung cancer, Severe neutropenia, Hematological toxicity